Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

German autoimmune disease IVD company seeks investment.

Project region Germany
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365


  • Simon Laube

    Simon Laube

    Assistant Manager, International Business Advisory

Project highlights To be confirmed
Project description

The company mainly develops and produces autoimmune disease diagnostic reagent products for early detection, diagnosis and prediction of autoimmune diseases. At present, the company has introduced more than 150 products in the field of diagnostic reagents. Main diagnostics include rheumatology, thrombosis, gastroenterology, vasculitis, thyroid, diabetes, liver disease and lyme disease ELISA detection, immunofluorescence based on cell and tissue slides, and IFA. With more than 200 employees in 20 countries and sales in more than 90 countries.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive